Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71M Buy
675,000
+225,000
+50% +$26.4M 1.23% 10
2025
Q4
$56.2M Buy
450,000
+250,000
+125% +$29.8M 0.92% 22
2025
Q3
$24M Sell
200,000
-267,700
-57% -$28.3M 0.33% 110
2025
Q2
$42.9M Buy
467,700
+217,700
+87% +$19.9M 0.72% 44
2025
Q1
$22M Sell
250,000
-100,000
-29% -$9.83M 0.44% 79
2024
Q4
$32.4M Buy
+350,000
New +$33.7M 0.77% 44
2024
Q3
Sell
-100,000
Closed -$7.5M 282
2024
Q2
$7.5M Hold
100,000
0.15% 165
2024
Q1
$8.63M Buy
+100,000
New +$7.64M 0.18% 164

Other funds holding CRH

Scopus Asset Management's CRH Position: Q1 2026 in Review

Scopus Asset Management increased its CRH (CRH) stake by 25% in Q1 2026, buying an estimated $23.5M and bringing the position to 1,002,596 shares worth $105M. The position accounts for 1.83% of the portfolio, ranked #4.

Scopus Asset Management first reported a position in CRH in Q3 2023 and has held it in 11 quarters since. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Scopus Asset Management held 1,002,596 shares of CRH worth $105M as of Q1 2026.
  • Scopus Asset Management bought 200,000 CRH shares in Q1 2026, an estimated $23.5M.
  • CRH made up 1.83% of Scopus Asset Management's portfolio in Q1 2026, its #4 holding.
  • Scopus Asset Management first reported a position in CRH in Q3 2023 and has held it in 11 quarters since.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Scopus Asset Management's 13F filing for Q1 2026, filed 15 May 2026.